News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Economides Vassiliki
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
4
| Economides Vassiliki (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Bought 12,000 shares
@ $1.9024, valued at
$22.8k
|
|
| 02/06/2023 |
4
| Economides Vassiliki (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 179,058 shares
@ $0 |
|
| 04/20/2022 |
4
| Economides Vassiliki (EVP & CFO) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 23,000 shares
@ $0
Granted 138,000 options to buy
@ $5.46, valued at
$753.5k
|
|
| 06/25/2021 |
4
| Economides Vassiliki (EVP & CFO) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 215,000 options to buy
@ $9.76, valued at
$2.1M
|
|
| 06/25/2021 |
3
| Economides Vassiliki (EVP & CFO) has filed a Form 3 on Gritstone bio, Inc. |
| 03/29/2021 |
4
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 750 shares
@ $10.19, valued at
$7.6k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 5,769 shares
@ $2.6, valued at
$15k
|
|
| 01/13/2020 |
4
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 62,500 options to buy
@ $3.29, valued at
$205.6k
|
|
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2019 |
4
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 350 shares
@ $4.4102, valued at
$1.5k
|
|
| 08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2019 |
4
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 431 shares
@ $5.8207, valued at
$2.5k
|
|
| 03/06/2019 |
4
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 70,000 options to buy
@ $20.25, valued at
$1.4M
|
|
| 03/06/2019 |
3
| Economides Vassiliki (SVP, Strategy & External Aff.) has filed a Form 3 on Kezar Life Sciences, Inc. |
|
|